Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Dev Neurosci ; 2024 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-39285780

RESUMEN

BACKGROUND: Finding effective pharmacological interventions to address the complex array of neurodevelopmental disorders is currently an urgent imperative within the scientific community as these conditions present significant challenges for patients and their families, often impacting cognitive, emotional, and social development. In this study, we aimed to explore non-invasive method to diagnose autism spectrum disorders (ASD) within Pakistan children population and to identify clinical drugs for its treatment. AIMS: The current report outlines a comprehensive bidirectional investigation showcasing the successful utilization of saliva samples to quantify the expression patterns of profilins (PFN1, 2, and 3); and ERM (ezrin, radixin, and moesin) proteins; and additionally moesin pseudogene 1 and moesin pseudogene 1 antisense (MSNP1AS). Subsequently, these expression profiles were employed to forecast interactions between drugs and genes in children diagnosed with ASD. METHODS: This study sought to delve into the intricate gene expression profiles using qualitative polymerase chain reaction of profilin isoforms (PFN1, 2, and 3) and ERM genes extracted from saliva samples obtained from children diagnosed with ASD. Through this analysis, we aimed to elucidate potential molecular mechanisms underlying ASD pathogenesis, shedding light on novel biomarkers and therapeutic targets for this complex neurological condition. (n = 22). Subsequently, we implemented a diagnostic model utilizing sparse partial least squares discriminant analysis (sPLS-DA) to predict drugs against our genes of interest. Furthermore, connectivity maps were developed to illustrate the predicted associations of 24 drugs with the genes expression. RESULTS: Our study results showed varied expression profile of cytoskeleton linked genes. Similarly, sPLS-DA model precisely predicted drug to genes response. Sixteen of the examined drugs had significant positive correlations with the expression of the targeted genes whereas eight of the predicted drugs had shown negative correlations. CONCLUSION: Here we report the role of cytoskeleton linked genes (PFN and ERM) in co-relation to ASD. Furthermore, variable yet significant quantitative expression of these genes successfully predicted drug-gene interactions as shown with the help of connectivity maps that can be used to support the clinical use of these drugs to treat individuals with ASD in future studies.

2.
Adv Sci (Weinh) ; 10(29): e2301423, 2023 10.
Artículo en Inglés | MEDLINE | ID: mdl-37594661

RESUMEN

Alzheimer's disease (AD) is a leading form of dementia where the presence of extra-neuronal plaques of Amyloid-ß (Aß) is a pathological hallmark. However, Aß peptide is also observed in the intestinal tissues of AD patients and animal models. In this study, it is reported that Aß monomers can target and disintegrate microbial amyloids of FapC and CsgA formed by opportunistic gut pathogens, Pseudomonas aeruginosa and Escherichia coli, explaining a potential role of Aß in the gut-brain axis. Employing a zebrafish-based transparent in vivo system and whole-mount live-imaging, Aß is observed to diffuse into the vasculature and subsequently localize with FapC or CsgA fibrils that were injected into the tail muscles of the fish. FapC aggregates, produced after Aß treatment (Faß), present selective toxicity to SH-SY5Y neuronal cells while the intestinal Caco-2 cells are shown to phagocytose Faß in a non-toxic cellular process. After remodeling by Aß, microbial fibrils lose their native function of cell adhesion with intestinal Caco-2 cells and Aß dissolves and detaches the microbial fibrils already attached to the cell membrane. Taken together, this study strongly indicates an anti-biofilm role for Aß monomers that can help aid in the future development of selective anti-Alzheimer's and anti-infective medicine.


Asunto(s)
Enfermedad de Alzheimer , Neuroblastoma , Animales , Humanos , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/metabolismo , Células CACO-2 , Pez Cebra/metabolismo , Péptidos beta-Amiloides/química , Péptidos beta-Amiloides/metabolismo , Amiloide/metabolismo , Escherichia coli/metabolismo , Biopelículas
3.
Gene ; 787: 145614, 2021 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-33775850

RESUMEN

Pfn3 is an intron-less gene, encoding actin binding protein that affects structure of cytoskeleton. Although, Pfn3 is mentioned in Allen Brain Atlas and in adult and prenatal Human Brain Tissue Gene Expression Profiles dataset, however, no report on brain and/or brain tumor associated Pfn3 nucleotide sequences are available in the databases. Moreover, pfn3 and pfn4 are always considered as testicular specific genes. The current study explored transcriptional expression profile and genetic architecture of pfn3 in a cohort of fifty formalin fixed paraffin embedded (FFPE) human glioma archive tissues. Results of designed study highlighted the significant dysregulated transcriptional pattern of pfn3. Molecular similarity index indicated 97% in nucleotide and 93% homology in protein sequences (with clear differences in nine amino acid residues). Thus, molecular variations in the pfn3 may be corelated with the malignancy of brain tumors, as previously, pfn1 and pfn2 were reported as tumor suppressor genes in other types of cancer.


Asunto(s)
Neoplasias Encefálicas/genética , Glioma/genética , Profilinas/genética , Formaldehído , Regulación Neoplásica de la Expresión Génica , Glioma/metabolismo , Humanos , Adhesión en Parafina , Profilinas/biosíntesis , Isoformas de Proteínas/genética , Fijación del Tejido , Transcriptoma
4.
Neurosci Biobehav Rev ; 103: 178-199, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31125634

RESUMEN

In 2016 the World Health Organization reported 39% of the world's adult population (over 18 y) was overweight, with western countries such as Australia and the United States of America at 64.5% and 67.9% respectively. Overconsumption of high fat/sugar containing food and beverages contribute to the development of obesity. Neural plasticity that occurs as a result of long term sugar consumption has been shown to reduce impulse control and therefore lower the ability to resist the high fat/sugar foods contributing to the obesity epidemic. There is significant overlap between the neural pathways involved in emotions that guide behavioural responses to survival situations with those regulating overconsumption of highly palatable food. This suggests that having a clearer understanding of the role of stress and emotions in the development of obesity will lead to the development of novel therapeutic strategies. Sucrose consumption activates the mesocorticolimbic system in a manner synonymous with substances of abuse. There is overwhelming evidence to support the hypothesis that sucrose consumption results in pathophysiological consequences such as morphological neuronal changes, altered emotional processing and modified behaviour in rodent and human models. In this comprehensive review, we examined >300 studies investigating the interaction between sugar consumption, stress and emotions. Preclinical and clinical trials investigating highly palatable foods and stress, anxiety, depression and fear are reviewed. Importantly, the synergy between sugar consumption and neurobiology is addressed. This review summarizes the neurochemical changes and neural adaptations ö including changes in the dopaminergic system ö that influence emotion and behaviour following sugar consumption.


Asunto(s)
Síntomas Afectivos , Conducta Adictiva/inducido químicamente , Encéfalo , Disfunción Cognitiva , Dieta de Carga de Carbohidratos/efectos adversos , Azúcares de la Dieta/efectos adversos , Conducta Alimentaria/efectos de los fármacos , Conducta Impulsiva/efectos de los fármacos , Trastornos Mentales/metabolismo , Obesidad , Estrés Psicológico , Síntomas Afectivos/metabolismo , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Disfunción Cognitiva/inducido químicamente , Disfunción Cognitiva/metabolismo , Humanos , Obesidad/inducido químicamente , Obesidad/metabolismo , Estrés Psicológico/metabolismo
5.
Int J Dev Neurosci ; 68: 106-110, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29906485

RESUMEN

Ezrin, Radixin and Moesin (ERM) are critical membranous component involved in cross-linking of actin filaments. Moesin (Msn) is recognized as a pivotal protein involved in regulation of cell signalling events associated with the maintenance of epithelial integrity, actin organization and polarity. Radixin (Rad) is known to cell-to-cell adherens junction as a barbed end-capping protein whereas ezrin (Ezr) is recognized at cell adhesion, motility, apoptosis and phagocytosis. The current study for the first time reports the transcriptional and RNA secondary structural variations among brain-specific ERM genes. Firstly, we analyzed brain-specific transcriptomic expression in selected embryonic and postnatal developmental stages (E10.5, E14.5, E18.5, P0.5, P3.5, P5.5, P10.5 and P20.5) of Mus musculus. Among designated developmental stages, Ezr has highest fold difference in early embryonic and postnatal stages (E10.5, P0.5 and P5.5). Rad showed a similar pattern of high expression especially at embryonic stages (E10.5 and E18.5) and postnatal (P0.5 and P5.5), however, Msn exhibited non-significant fold differences in comparison to controls leading to its curial role in development. Furthermore, computational prediction of ERM coding mRNA transcripts, reveals compact and less dynamic Msn secondary structure and pseudoknots configurations, in contrast to Ezr and Rad. Conclusively, transcriptomic levels are greatly associated with compact base pairing organization of its secondary structures. These findings open a new domain to understand the occurrence of ERM-specific cytoskeleton proteins during developmental stages.


Asunto(s)
Encéfalo , Proteínas del Citoesqueleto/metabolismo , Regulación del Desarrollo de la Expresión Génica/fisiología , Proteínas de la Membrana/metabolismo , Proteínas de Microfilamentos/metabolismo , Factores de Edad , Animales , Animales Recién Nacidos , Encéfalo/embriología , Encéfalo/crecimiento & desarrollo , Encéfalo/metabolismo , Proteínas del Citoesqueleto/genética , Embrión de Mamíferos , Proteínas de la Membrana/genética , Ratones , Proteínas de Microfilamentos/genética , Modelos Moleculares , ARN Mensajero
6.
Mol Cell Probes ; 31: 76-84, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27618775

RESUMEN

Autophagy is crucial for maintaining physiological homeostasis, but its role in infectious diseases is not yet adequately understood. The binding of Anaplasma translocated substrate-1 (ATS1) to the human Beclin1 (BECN1) protein is responsible for the modulation of autophagy pathway. ATS1-BECN1 is a novel type of interaction that facilitates Anaplasma phagocytophilum proliferation, leading to intracellular infection via autophagosome induction and segregation from the lysosome. Currently, there is no report of post translational modifications (PTMs) of BECN1 or cross-talk required for ATS-BECN1 complex formation. Prediction/modeling of the cross-talk between phosphorylation and other PTMs (O-ß-glycosylation, sumoylation, methylation and palmitoylation) has been attempted in this study, which might be responsible for regulating function after the interaction of ATS1 with BECN1. PTMs were predicted computationally and mapped onto the interface of the docked ATS1-BECN1 complex. Results show that BECN1 phosphorylation at five residues (Thr91, Ser93, Ser96, Thr141 and Ser234), the interplay with O-ß-glycosylation at three sites (Thr91, Ser93 and Ser96) with ATS1 may be crucial for attachment and, hence, infection. No other PTM site at the BECN1 interface was predicted to associate with ATS1. These findings may have significant clinical implications for understanding the etiology of Anaplasma infection and for therapeutic studies.


Asunto(s)
Anaplasma phagocytophilum/metabolismo , Autofagosomas/metabolismo , Biología Computacional/métodos , Interacciones Huésped-Patógeno , Procesamiento Proteico-Postraduccional , Secuencia de Aminoácidos , Animales , Beclina-1/química , Beclina-1/metabolismo , Humanos , Ratones , Modelos Moleculares , Unión Proteica , Estructura Secundaria de Proteína , Ratas , Alineación de Secuencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA